High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial-Reference-Cited by-同舟云学术

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

Published:2019-04 Issue:4 Volume:6 Page:e217-e228
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Hutchison Colin A,Cockwell Paul,Moroz Veronica,Bradwell Arthur R,Fifer Lesley,Gillmore Julian D,Jesky Mark D,Storr Markus,Wessels Julie,Winearls Christopher G,Weisel Katja,Heyne Nils,Cook Mark

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

2. Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents;Dimopoulos;Ann Oncol,2014

3. A population-based study of the impact of dialysis on mortality in multiple myeloma;Evison;Br J Haematol,2018

4. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution;Bladé;Arch Intern Med,1998

5. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre;Haynes;Nephrol Dial Transplant,2010

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis;Hematology;2024-09-09

2. The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure;Biomedicines;2024-05-08

3. Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies;Antibodies;2024-03-11

4. Pushing the boundaries of hemodialysis: innovations in membranes and sorbents;Revista de investigaci�n Cl�nica;2023-12-20

5. How I Treat Light Chain Cast Nephropathy;Clinical Journal of the American Society of Nephrology;2023-12-18